![Brian Wiley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Wiley
Corporate Officer/Principal at
APREA THERAPEUTICS, INC.
Profile
Brian Wiley is the founder of Boston Bioconsulting LLC, founded in 2018.
Mr. Wiley is currently a Senior VP-Corporate Development & Strategy at Aprea Therapeutics, Inc. since 2023.
Former positions include Senior Director-Oncology Marketing at Celgene Corp., Director-Market Planning at Millennium Pharmaceuticals, Inc., Senior Director-Marketing & Business Development at Gloucester Pharmaceuticals, Inc., Chief Commercial Officer at NewLink Genetics Corp.
from 2016 to 2018, and Senior Manager at Aventis Pharmaceuticals, Inc. from 1992 to 2004.
Mr. Wiley is also the Chief Business Officer at Portage Biotech, Inc. from 2022 to 2024.
Education includes an undergraduate degree from The Pennsylvania State University.
Brian Wiley active positions
| Companies | Position | Start |
|---|---|---|
| APREA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2023 |
Former positions of Brian Wiley
| Companies | Position | End |
|---|---|---|
| ALPHA COMPUTE CORP | Corporate Officer/Principal | 15/11/2024 |
| LUMOS PHARMA, INC. | Corporate Officer/Principal | 27/07/2018 |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Sales & Marketing | 26/04/2011 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01/01/2004 |
Boston Bioconsulting LLC | Founder | - |
Training of Brian Wiley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
44
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
AlphaTON Capital Corp.
 AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Bioconsulting LLC | |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
- Stock Market
- Insiders
- Brian Wiley
